Detalles de la búsqueda
1.
Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective study.
Genet Med
; 20(10): 1284-1294, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29565424
2.
Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.
Mol Genet Metab
; 119(1-2): 115-23, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27473031
3.
Distal femoral osteotomy: is internal fixation better than external?
Clin Orthop Relat Res
; 469(7): 2003-11, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21210313
4.
Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose study.
Neuromuscul Disord
; 29(3): 167-186, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30770310
5.
A Phase 4 Prospective Study in Patients with Adult Pompe Disease Treated with Alglucosidase Alfa.
J Neuromuscul Dis
; 2(s1): S72-S73, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-27858658
6.
Ipsilateral fibular transport using Ilizarov-Taylor spatial frame for a limb salvage reconstruction: a case report.
HSS J
; 5(1): 31-9, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19034585
Resultados
1 -
6
de 6
1
Próxima >
>>